tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,537 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is -5.65, suggesting Tvardi Therapeutics is a Sell.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 8.79, while Tvardi Therapeutics’s (TVRD) share price is $4.19, making it a Sell.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 17.39, while Tvardi Therapeutics’s (TVRD) share price is $4.19, making it a Sell.

Tvardi Therapeutics (TVRD) Pivot Points

Nov 11, 2025, 11:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.50
3.67
3.85
4.02
4.20
4.37
4.55
Fibonacci
3.67
3.81
3.89
4.02
4.16
4.24
4.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

Nov 11, 2025, 11:54 AM
Period
Simple
Exponential
MA5
4.15Buy
4.21Sell
MA10
4.41Sell
4.95Sell
MA20
5.14Sell
8.79Sell
MA50
23.16Sell
17.39Sell
MA100
24.32Sell
21.21Sell
MA200
22.01Sell
20.15Sell
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 4.95, while Tvardi Therapeutics’s (TVRD) share price is $4.19, making it a Sell.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 21.21, while Tvardi Therapeutics’s (TVRD) share price is $4.19, making it a Sell.
Tvardi Therapeutics’s (TVRD) stock price is $4.19 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 23.16, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) stock price is $4.19 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 24.32, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) stock price is $4.19 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 22.01, creating a Sell signal.

Tvardi Therapeutics (TVRD) Technical Indicators

Nov 11, 2025, 11:54 AM
Name
Value
Implied Action
RSI (14)
19.48
Buy
STOCH (9,6)
15.70
Buy
STOCHRSI (14)
8.41
Buy
MACD (12,26)
-5.65
Sell
ADX (14)
56.68
Sell
Williams %R
-83.41
Buy
CCI (14)
-86.13
Neutral
ATR (14)
1.47
-
Ultimate Oscillator
31.24
Neutral
ROC
-26.62
Sell
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 19.48, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 56.68, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is -86.13, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is -26.62, creating a Sell signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Sell.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 19.48, which suggests TVRD is a Buy.
      What is TVRD’s MACD?
      TVRD’s MACD is -5.65, which suggests TVRD is a Sell.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 4.15, which suggests TVRD is a Buy.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 5.14, which suggests TVRD is a Sell.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 23.16, which suggests TVRD is a Sell.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 22.01, which suggests TVRD is a Sell.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -83.41, which suggests TVRD is a Buy.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is -86.13, which suggests TVRD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis